No article text was recorded for this version.
immunodeficient model limitations
Version 1 of 161 papers68 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Establishment and Application of Patient-derived Tumour Xenograft Model
- Blog: Predictive value of preclinical models for CAR-T cell therapy clinical trials: a systematic review and meta-analysis
- Blog: Fenofibrate Increases Radiosensitivity in Head and Neck Squamous Cell Carcinoma via Inducing G2/M Arrest and Apoptosis
- Blog: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines
- Blog: Dasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling
- Blog: Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells
- Blog: Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies
- Blog: CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation
- Blog: Circ_0061140 knockdown inhibits tumorigenesis and improves PTX sensitivity by regulating miR-136/CBX2 axis in ovarian cancer
- Blog: Identification of CD146 as a marker enriched for tumor-propagating capacity reveals targetable pathways in primary human sarcoma
- Blog: HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical models
- Blog: Experimental mouse models for translational human cancer research
- Blog: Bevacizumab potentiates chemotherapeutic effect on T-leukemia/lymphoma cells by direct action on tumor endothelial cells
- Blog: Establishment of an Immunocompetent Metastasis Rat Model with Hepatocyte Cancer Stem Cells
- Blog: Spatiotemporal profiling reveals distinct dynamics and checkpoint regulations of CAR-T and CAR-NKT cells against solid tumors
- Blog: Systematic annotation of orphan RNAs reveals blood-accessible molecular barcodes of cancer identity and cancer-emergent oncogenic drivers
- Blog: 1079 Discovery of a novel DLL3/CD3 bispecific T cell engager for treating SCLC
- Blog: Autologous humanized PDX modeling for immuno-oncology recapitulates features of the human tumor microenvironment
- Blog: AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple-negative breast cancer
- Blog: Primary and recurrent glioma patient-derived orthotopic xenografts (PDOX) represent relevant patient avatars for precision medicine
- Blog: Emodin induces Panc-1 cell apoptosis via declining the mitochondrial membrane potential
- Blog: EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells
- Blog: MiR-4319 induced an inhibition of epithelial-mesenchymal transition and prevented cancer stemness of HCC through targeting FOXQ1
- Blog: Chemokine Receptor CCR2b Enhanced Anti-tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-small-cell Lung Carcinoma Model
- Blog: STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells
- Blog: Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft model
- Blog: A 3D multiscale model of cancer stem cell in tumor development
- Blog: Oncolytic herpes simplex virus delivery of dual CAR targets of CD19 and BCMA as well as immunomodulators to enhance therapeutic efficacy in solid tumors combined with CAR T cell therapy
- Blog: The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell Malignancies
- Blog: Suppressive effects of Momordica charantia MAP30 on the senescence, proliferation and migration of bladder cancer cells mediated by CENPA
- Blog: Personalized Treatment of Advanced Gastric Cancer Guided by the MiniPDX Model
- Blog: Endometrium-derived mesenchymal stem cells suppress progression of endometrial cancer via the DKK1-Wnt/β-catenin signaling pathway
- Blog: A bi-steric mTORC1-selective inhibitor overcomes drug resistance in breast cancer
- Blog: Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines
- Blog: Single-cell analysis of patient-derived PDAC organoids reveals cell state heterogeneity and a conserved developmental hierarchy
- Blog: Interleukin-21 engineering enhances CD19-specific CAR-NK cell activity against B-cell lymphoma via enriched metabolic pathways
- Blog: SOX2-induced IL1α-mediated immune suppression drives epithelial dysplasia malignant transformation
- Blog: Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer
- Blog: AZGP1 deficiency promotes angiogenesis in prostate cancer
- Blog: Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations
- Blog: Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology
- Blog: A Computational Model of Inhibition of HIV-1 by Interferon-Alpha
- Blog: Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth
- Blog: Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrence
- Blog: Investigation of a clinical trial drug VV261 as a potent antiviral candidate against Chikungunya virus
- Blog: ProMPt: A modular preclinical platform for functional modelling of prostate cancer heterogeneity and therapeutic vulnerabilities
- Blog: Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
- Blog: Establishment of a Hyperacute Rejection Model of ABO-Incompatible Renal Transplantation in Nonhuman Primates
- Blog: Development of a novel prognostic nomogram for AIDS-associated diffuse large B-cell lymphoma: a retrospective study from northern China
- Blog: Young glial progenitor cells competitively replace aged and diseased human glia in the adult chimeric mouse brain
- Blog: Human Hyaluronidase PH20 Potentiates the Antitumor Activities of Mesothelin-Specific CAR-T Cells Against Gastric Cancer
- Blog: OPS-γδ: allogeneic opsonin-secreting γδT cell immunotherapy for solid tumours mediates direct and bystander immunity
- Blog: Proteomic Characterization of Intrahepatic Cholangiocarcinoma Identifies Distinct Subgroups and Proteins Associated with Time-To-Recurrence
- Blog: ArgR-dependent bacterial resistance to host lipid droplets in Edwardsiella piscicida
- Blog: Relating hepatocellular carcinoma tumor samples and cell lines using gene expression data in translational research
- Blog: Decorin-armed oncolytic adenovirus promotes natural killers (NKs) activation and infiltration to enhance NK therapy in CRC model
- Blog: Combining CD38 antibody with CD47 blockade is a promising strategy for treating hematologic malignancies expressing CD38
- Blog: TMT-Based Quantitative Proteomic Analysis of Intestinal Organoids Infected by Listeria monocytogenes Strains with Different Virulence
- Blog: Intravenous Transplantation of Human Hair Follicle-Derived Mesenchymal Stem Cells Ameliorates Trabecular Bone Loss in Osteoporotic Mice
- Blog: Antimetastatic Effects of Ganoderma lucidum Polysaccharide Peptide on B16-F10-luc-G5 Melanoma Mice With Sleep Fragmentation
Showing 60 of 61 papers.
History & citation
Current · Permanent link
- The Limitations of Immunodeficient Models in Preclinical Research merged into this direction (58% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_immunodeficient_model_limitations_2fe2960e,
title = {immunodeficient model limitations},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/immunodeficient-model-limitations/rdr_2fe2960e3bf44864a0eba512f3379322},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 1, frozen text):
@misc{lacuna_immunodeficient_model_limitations_2fe2960e_v1,
title = {immunodeficient model limitations},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/immunodeficient-model-limitations/rdr_2fe2960e3bf44864a0eba512f3379322/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}